FR

Frasers Group PLCLSE Frasers Group Stock Report

Last reporting period 28 Apr, 2024

Updated 01 Nov, 2024

Last price

Market cap $B

4.654

Middle

Exchange

XLON - London Stock Exchange

FRAS.L Stock Analysis

FR

Neutral

Based on Eyestock quantitative analysis, FRAS.L`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

62/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

20.6 %

Undervalued

Market cap $B

4.654

Dividend yield

Shares outstanding

437.39 B

Frasers Group Plc engages in the retail of sporting goods. The company is headquartered in Shirebrook, Nottinghamshire and currently employs 30,353 full-time employees. The company went IPO on 2007-03-02. The firm operates a diversified portfolio of sports, fitness, premium lifestyle and luxury fascias in over 20 countries. Its UK Sports Retail segment includes its sports retail and USC store operations in the UK, all of its sports online businesses, its gyms, Evans Cycles, and its Shirebrook campus operations. Its Premium Lifestyle segment offers and luxury offering, consisting of the Flannels, Cruise, van mildert, Jack Wills, House of Fraser and Sofa.com along with the related websites. Its European Retail segment includes sports retail stores, management and operations in Europe, including its European distribution centers in Belgium and Austria, as well as GAME Spain stores and Baltics online. Its Rest of World Retail segment includes Asia based retail activities, along with their e-commerce offerings. The Wholesale & Licensing segment includes a portfolio of international brands, such as Everlast, others.

View Section: Eyestock Rating